BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 22472348)

  • 1. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
    Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
    Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer.
    Miyake K; Shimada M; Nishioka M; Sugimoto K; Batmunkh E; Uto Y; Nagasawa H; Hori H
    Cancer Lett; 2008 Dec; 272(2):325-35. PubMed ID: 18762366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
    Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
    Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apigenin down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells.
    Melstrom LG; Salabat MR; Ding XZ; Strouch MJ; Grippo PJ; Mirzoeva S; Pelling JC; Bentrem DJ
    J Surg Res; 2011 May; 167(2):173-81. PubMed ID: 21227456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
    Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H
    PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
    Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
    Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.
    Akakura N; Kobayashi M; Horiuchi I; Suzuki A; Wang J; Chen J; Niizeki H; Kawamura Ki ; Hosokawa M; Asaka M
    Cancer Res; 2001 Sep; 61(17):6548-54. PubMed ID: 11522653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptolide suppresses proliferation, hypoxia-inducible factor-1α and c-Myc expression in pancreatic cancer cells.
    Ding X; Zhou X; Jiang B; Zhao Q; Zhou G
    Mol Med Rep; 2015 Sep; 12(3):4508-4513. PubMed ID: 26094625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer.
    Wei H; Li F; Fu P; Liu X
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):436-46. PubMed ID: 23467940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
    Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
    J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L: -ascorbate on pancreatic tumors in athymic mice.
    Chen C; Sun J; Liu G; Chen J
    Pathol Oncol Res; 2009 Mar; 15(1):109-14. PubMed ID: 18509748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of lentiviral vector-mediated RNA interference targeting hypoxia-inducible factor 1α on the uptake of fluorodeoxyglucose ((18)f) in the human pancreatic cancer cell line, patu8988.
    Fan G; Bo J; Wan R; Peng M; Luan Y; Deng M; Xu L
    Cancer Biother Radiopharm; 2015 May; 30(4):160-8. PubMed ID: 25853522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
    Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
    Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of hypoxia-inducible factor-1 alpha in RPMI8226 myeloma cells results in reduced tumor growth in nude mice].
    Li BZ; Zhuang WZ; Chen P; Fu JX
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):247-51. PubMed ID: 18843979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
    Zhu DM; Li DC; Zhang ZX; Zhang XY
    Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
    Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
    Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.
    Xia T; Cheng H; Zhu Y
    Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis.
    Terzuoli E; Donnini S; Giachetti A; Iñiguez MA; Fresno M; Melillo G; Ziche M
    Clin Cancer Res; 2010 Aug; 16(16):4207-16. PubMed ID: 20682710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmenting tumor sensitivity to topotecan by transient hypoxia.
    Lund EL; Hansen LT; Kristjansen PE
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):473-80. PubMed ID: 15895231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy.
    Yoon C; Chang KK; Lee JH; Tap WD; Hart CP; Simon MC; Yoon SS
    Oncotarget; 2016 Jul; 7(28):42844-42858. PubMed ID: 27374091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.